286 related articles for article (PubMed ID: 8629039)
21. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
23. Eastern Cooperative Oncology Group studies of paclitaxel and doxorubicin in advanced breast cancer.
Sledge GW; Robert N; Sparano JA; Cogleigh M; Goldstein LJ; Neuberg D; Rowinsky E; Baughman C; McCaskill-Stevens W
Semin Oncol; 1995 Jun; 22(3 Suppl 6):105-8. PubMed ID: 7597425
[TBL] [Abstract][Full Text] [Related]
24. Sequential adjuvant therapy: the Memorial Sloan-Kettering Cancer Center experience.
Hudis C; Seidman A; Raptis G; Fennelly D; Gilewski T; Baselga J; Theodoulou M; Sklarin N; Moynahan M; Surbone A; Currie V; Lebwohl D; Uhlenhopp M; Crown J; Norton L
Semin Oncol; 1996 Feb; 23(1 Suppl 1):58-64. PubMed ID: 8629040
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel doublets in metastatic breast cancer: Eastern Cooperative Oncology Group and Hoosier Oncology Group Studies.
Sledge GW
Semin Oncol; 1996 Oct; 23(5 Suppl 11):57-9. PubMed ID: 8893901
[TBL] [Abstract][Full Text] [Related]
26. Future developments for paclitaxel in the treatment of breast cancer.
Bonadonna G
Semin Oncol; 1996 Feb; 23(1 Suppl 1):65-8. PubMed ID: 8629041
[TBL] [Abstract][Full Text] [Related]
27. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
28. Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer.
Conte PF; Baldini E; Michelotti A; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Giannessi PG; Gentile A
Semin Oncol; 1996 Dec; 23(6 Suppl 15):39-42. PubMed ID: 8996597
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.
Lück HJ; Thomssen C; du Bois A; Untch M; Lisboa B; Köhler G; Diergarten K
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-35-S17-39. PubMed ID: 9374090
[TBL] [Abstract][Full Text] [Related]
30. Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.
Klaassen U; Wilke H; Müller C; Borquez D; Harstrick A; Seeber S
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-58-S17-60. PubMed ID: 9374095
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.
Dombernowsky P; Gehl J; Boesgaard M; Paaske T; Jensen BV
Semin Oncol; 1996 Oct; 23(5 Suppl 11):23-7. PubMed ID: 8893895
[TBL] [Abstract][Full Text] [Related]
32. Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience.
Catimel G; Spielmann M; Dieras V; Tubiana-Hulin M; Bonneterre J; Pouillart P; Kayitalire L; Guastalla JP; Graffand N; Garet F; Dumortier A; Pellae-Cosset B
Semin Oncol; 1997 Feb; 24(1 Suppl 3):S8-12. PubMed ID: 9071333
[TBL] [Abstract][Full Text] [Related]
33. Single-agent paclitaxel for the treatment of breast cancer: an overview.
Hortobagyi GN; Holmes FA
Semin Oncol; 1996 Feb; 23(1 Suppl 1):4-9. PubMed ID: 8629036
[TBL] [Abstract][Full Text] [Related]
34. Combination paclitaxel (Taxol) and doxorubicin therapy for metastatic breast cancer.
O'Shaughnessy JA; Fisherman JS; Cowan KH
Semin Oncol; 1994 Oct; 21(5 Suppl 8):19-23. PubMed ID: 7939757
[TBL] [Abstract][Full Text] [Related]
35. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of paclitaxel or doxorubicin used as single agents in advanced breast cancer: a literature survey.
Paridaens R
Semin Oncol; 1998 Oct; 25(5 Suppl 12):3-6. PubMed ID: 9865704
[TBL] [Abstract][Full Text] [Related]
37. Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer.
D'Andrea G; Fennelly D; Norton L; Baselga J; Gilewski T; Hudis C; Moynahan ME; Raptis G; Sklarin N; Surbone A; Theodoulou M; Templeton MA; Yao TJ; Seidman AD
Clin Cancer Res; 1999 Feb; 5(2):275-9. PubMed ID: 10037175
[TBL] [Abstract][Full Text] [Related]
38. The role of paclitaxel in the therapy of bladder cancer.
Roth BJ
Semin Oncol; 1995 Oct; 22(5 Suppl 12):33-40. PubMed ID: 7481859
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel and carboplatin for advanced breast cancer.
Perez EA; Hartmann LC
Semin Oncol; 1996 Oct; 23(5 Suppl 11):41-5. PubMed ID: 8893899
[TBL] [Abstract][Full Text] [Related]
40. The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer.
Hortobagyi GN; Holmes FA; Ibrahim N; Champlin R; Buzdar AU
Semin Oncol; 1997 Feb; 24(1 Suppl 3):S30-3. PubMed ID: 9071338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
